Certara Inc (CERT)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $1.76B
Last updated: Nov 17, 2026 at 11:05 AM ET
Certara Inc (CERT) P/E Ratio & Valuation History
Certara (CERT) trades at 45.6x trailing earnings and 4.4x sales. Its P/E of 45.6x is above its 5-year median of 35.7x. Its forward P/E is 27.2x. The median P/E across 6 similar companies is 26.5x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 67.6% higher over the next year. Its free cash flow yield is 3.0%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 45.6x |
| Forward P/E | 27.2x |
| Price to sales | 4.4x |
| Price to book | 1.8x |
| EV/EBITDA | 25.9x |
| Price to FCF | 33.8x |
| EV/FCF | 35.3x |
| PEG | N/A |
| FCF yield | 3.0% |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 45.6x | 35.7x | N/A |
| P/S | 4.4x | 6.2x | N/A |
| P/B | 1.8x | 2.1x | N/A |
Valuation History
Over the 5 of the 6 year ends shown that have a P/E, its P/E ranged from 22.0x in 2025 to 167.2x in 2021. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $8.81 | 22.0x | 3.6x | 1.3x |
| 2024 | $10.65 | 23.7x | 4.4x | 1.6x |
| 2023 | $17.59 | 40.0x | 7.9x | 2.7x |
| 2022 | $16.07 | 34.9x | 7.5x | 2.4x |
| 2021 | $28.42 | 167.2x | 14.9x | 4.2x |
| 2020 | $33.72 | N/A | 20.5x | 5.6x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About CERT
What is CERT's forward P/E ratio?
Certara has a forward P/E ratio of 27.2x.
Is CERT stock overvalued?
GNG's valuation label for CERT is Undervalued. Its P/E of 45.6x compares with a median of 26.5x across 6 similar companies.
What is CERT's price to sales ratio?
Certara has a price to sales ratio of 4.4x.
What is Certara's average P/E ratio over 5 years?
Certara's median P/E over the last 5 years is 35.7x, from 60 month-end values through Oct 2026.
CERT pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors